BioPharma Dive17m
Lilly expands US manufacturing build-out with $50B target
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...
Lilly plans to build four new pharmaceutical manufacturing sites in the U.S.
Eli Lilly (LLY) and Company announced at plans to bolster its domestic medicine production across therapeutic areas by building four new ...
Eli Lilly Plans to Spend $27 Billion on New U.S. Plants
Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company ...
Eli Lilly to build 4 more manufacturing sites in US
Eli Lilly announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will p ...
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, ...